Major Estimate Revision • May 29
Consensus EPS estimates increase by 42% The consensus outlook for earnings per share (EPS) in fiscal year 2026 has improved. 2026 revenue forecast increased from NT$294.1b to NT$312.6b. EPS estimate increased from NT$6.26 to NT$8.92 per share. Net income forecast to grow 275% next year vs 72% growth forecast for Chemicals industry in Taiwan. Consensus price target up from NT$84.50 to NT$92.00. Share price rose 13% to NT$98.10 over the past week. Valuation Update With 7 Day Price Move • May 27
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to NT$95.40, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 20x in the Chemicals industry in Taiwan. Total returns to shareholders of 33% over the past three years. Reported Earnings • May 14
First quarter 2026 earnings: EPS and revenues exceed analyst expectations First quarter 2026 results: EPS: NT$1.80 (up from NT$0.057 in 1Q 2025). Revenue: NT$68.6b (up 4.6% from 1Q 2025). Net income: NT$14.3b (up NT$13.8b from 1Q 2025). Profit margin: 21% (up from 0.7% in 1Q 2025). The increase in margin was primarily driven by lower expenses. Revenue exceeded analyst estimates by 5.5%. Earnings per share (EPS) also surpassed analyst estimates. Revenue is forecast to grow 9.8% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Price Target Changed • Apr 15
Price target increased by 7.5% to NT$79.80 Up from NT$74.20, the current price target is an average from 5 analysts. New target price is 8.9% below last closing price of NT$87.60. Stock is up 181% over the past year. The company is forecast to post earnings per share of NT$6.02 for next year compared to NT$0.57 last year. Major Estimate Revision • Apr 14
Consensus EPS estimates increase by 72% The consensus outlook for earnings per share (EPS) in fiscal year 2026 has improved. 2026 revenue forecast increased from NT$280.5b to NT$293.3b. EPS estimate increased from NT$2.57 to NT$4.42 per share. Net income forecast to grow 675% next year vs 51% growth forecast for Chemicals industry in Taiwan. Consensus price target broadly unchanged at NT$75.20. Share price rose 11% to NT$89.00 over the past week. Reported Earnings • Mar 12
Full year 2025 earnings: EPS exceeds analyst expectations Full year 2025 results: EPS: NT$0.57 (up from NT$0.42 in FY 2024). Revenue: NT$259.9b (flat on FY 2024). Net income: NT$4.52b (up 35% from FY 2024). Profit margin: 1.7% (up from 1.3% in FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.3%. Revenue is forecast to grow 8.5% p.a. on average during the next 3 years, compared to a 7.6% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 90 percentage points per year, which is a significant difference in performance. Duyuru • Mar 12
Nan Ya Plastics Corporation, Annual General Meeting, May 29, 2026 Nan Ya Plastics Corporation, Annual General Meeting, May 29, 2026. Location: no,100, tun hua n. rd., taipei city Taiwan New Risk • Jan 07
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 8.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. This is currently the only risk that has been identified for the company. Price Target Changed • Dec 02
Price target increased by 28% to NT$51.50 Up from NT$40.38, the current price target is an average from 8 analysts. New target price is 19% below last closing price of NT$63.90. Stock is up 61% over the past year. The company is forecast to post earnings per share of NT$0.56 for next year compared to NT$0.42 last year. Price Target Changed • Nov 20
Price target increased by 11% to NT$42.88 Up from NT$38.75, the current price target is an average from 8 analysts. New target price is 24% below last closing price of NT$56.60. Stock is up 41% over the past year. The company is forecast to post earnings per share of NT$0.49 for next year compared to NT$0.42 last year. Reported Earnings • Nov 12
Third quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behind Third quarter 2025 results: EPS: NT$0.41 (up from NT$0.008 in 3Q 2024). Revenue: NT$64.2b (down 3.4% from 3Q 2024). Net income: NT$3.26b (up NT$3.19b from 3Q 2024). Profit margin: 5.1% (up from 0.1% in 3Q 2024). Revenue missed analyst estimates by 2.7%. Earnings per share (EPS) exceeded analyst estimates by 17%. Revenue is forecast to grow 3.4% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 97 percentage points per year, which is a significant difference in performance. Reported Earnings • Aug 13
Second quarter 2025 earnings: EPS misses analyst expectations Second quarter 2025 results: NT$0.52 loss per share (down from NT$0.22 profit in 2Q 2024). Revenue: NT$65.7b (down 1.0% from 2Q 2024). Net loss: NT$4.12b (down 337% from profit in 2Q 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 19%. Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 95 percentage points per year, which is a significant difference in performance. Price Target Changed • Aug 02
Price target increased by 9.2% to NT$37.75 Up from NT$34.57, the current price target is an average from 8 analysts. New target price is 5.2% below last closing price of NT$39.80. Stock is down 18% over the past year. The company is forecast to post earnings per share of NT$0.77 for next year compared to NT$0.42 last year. Major Estimate Revision • Jul 31
Consensus EPS estimates fall by 12% The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from NT$0.713 to NT$0.625 per share. Revenue forecast steady at NT$265.3b. Net income forecast to grow 180% next year vs 16% growth forecast for Chemicals industry in Taiwan. Consensus price target up from NT$34.57 to NT$36.71. Share price rose 27% to NT$41.00 over the past week. Major Estimate Revision • Jul 15
Consensus EPS estimates fall by 13% The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from NT$0.923 to NT$0.804 per share. Revenue forecast steady at NT$265.2b. Net income forecast to grow 180% next year vs 16% growth forecast for Chemicals industry in Taiwan. Consensus price target down from NT$36.57 to NT$34.57. Share price was steady at NT$27.65 over the past week. Upcoming Dividend • Jul 15
Upcoming dividend of NT$0.70 per share Eligible shareholders must have bought the stock before 22 July 2025. Payment date: 20 August 2025. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 2.5%. Lower than top quartile of Taiwanese dividend payers (5.3%). Lower than average of industry peers (3.2%). Declared Dividend • Jun 14
Dividend of NT$0.70 announced Dividend of NT$0.70 is the same as last year. Ex-date: 22nd July 2025 Payment date: 20th August 2025 Dividend yield will be 2.4%, which is lower than the industry average of 4.0%. Sustainability & Growth Dividend is not covered by earnings (174% earnings payout ratio) nor is it covered by cash flows (156% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 94% to bring the payout ratio under control. EPS is expected to grow by 290% over the next 3 years, which is sufficient to bring the dividend into a sustainable range. Reported Earnings • May 14
First quarter 2025 earnings: EPS misses analyst expectations First quarter 2025 results: EPS: NT$0.07 (down from NT$0.16 in 1Q 2024). Revenue: NT$65.6b (up 12% from 1Q 2024). Net income: NT$453.1m (down 64% from 1Q 2024). Profit margin: 0.7% (down from 2.1% in 1Q 2024). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 76%. Revenue is forecast to grow 1.4% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 79 percentage points per year, which is a significant difference in performance. Valuation Update With 7 Day Price Move • Apr 16
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to NT$31.30, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 17x in the Chemicals industry in Taiwan. Total loss to shareholders of 59% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at NT$47.64 per share. New Risk • Mar 16
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 174% Cash payout ratio: 90% Minor Risks Share price has been volatile over the past 3 months (6.0% average weekly change). Profit margins are more than 30% lower than last year (1.3% net profit margin). Reported Earnings • Mar 13
Full year 2024 earnings: Revenues in line with analyst expectations Full year 2024 results: Revenue: NT$259.6b (flat on FY 2023). Net income: NT$3.34b (down 47% from FY 2023). Profit margin: 1.3% (down from 2.4% in FY 2023). Revenue was in line with analyst estimates. Revenue is forecast to grow 3.2% p.a. on average during the next 2 years, compared to a 5.3% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 75 percentage points per year, which is a significant difference in performance. Duyuru • Mar 12
Nan Ya Plastics Corporation, Annual General Meeting, Jun 12, 2025 Nan Ya Plastics Corporation, Annual General Meeting, Jun 12, 2025. Location: no,100, tun hua n. rd., taipei city Taiwan Price Target Changed • Mar 12
Price target decreased by 7.2% to NT$36.57 Down from NT$39.43, the current price target is an average from 7 analysts. New target price is 7.6% above last closing price of NT$34.00. Stock is down 39% over the past year. The company is forecast to post earnings per share of NT$0.42 for next year compared to NT$0.80 last year. Duyuru • Mar 04
Nan Ya Plastics Corporation to Report Fiscal Year 2024 Results on Mar 11, 2025 Nan Ya Plastics Corporation announced that they will report fiscal year 2024 results on Mar 11, 2025 Major Estimate Revision • Jan 29
Consensus EPS estimates fall by 58%, revenue upgraded The consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from NT$251.0b to NT$258.2b. EPS estimate fell from NT$1.00 to NT$0.419 per share. Net income forecast to grow 373% next year vs 23% growth forecast for Chemicals industry in Taiwan. Consensus price target of NT$39.43 unchanged from last update. Share price was steady at NT$32.35 over the past week. Major Estimate Revision • Jan 17
Consensus EPS estimates fall by 42% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from NT$258.7b to NT$251.0b. EPS estimate also fell from NT$1.73 per share to NT$1.00 per share. Net income forecast to grow 427% next year vs 23% growth forecast for Chemicals industry in Taiwan. Consensus price target down from NT$49.42 to NT$40.50. Share price rose 16% to NT$32.85 over the past week. Price Target Changed • Jan 13
Price target decreased by 8.4% to NT$45.25 Down from NT$49.42, the current price target is an average from 6 analysts. New target price is 57% above last closing price of NT$28.85. Stock is down 55% over the past year. The company is forecast to post earnings per share of NT$1.73 for next year compared to NT$0.80 last year. Price Target Changed • Dec 11
Price target decreased by 9.3% to NT$49.42 Down from NT$54.51, the current price target is an average from 6 analysts. New target price is 37% above last closing price of NT$36.00. Stock is down 46% over the past year. The company is forecast to post earnings per share of NT$1.73 for next year compared to NT$0.80 last year. Reported Earnings • Nov 15
Third quarter 2024 earnings released: EPS: NT$0.008 (vs NT$0.55 in 3Q 2023) Third quarter 2024 results: EPS: NT$0.008 (down from NT$0.55 in 3Q 2023). Revenue: NT$66.4b (down 1.2% from 3Q 2023). Net income: NT$65.8m (down 99% from 3Q 2023). Profit margin: 0.1% (down from 6.5% in 3Q 2023). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 69 percentage points per year, which is a significant difference in performance. New Risk • Nov 14
New major risk - Revenue and earnings growth Earnings have declined by 11% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company. Duyuru • Nov 05
Nan Ya Plastics Corporation to Report Q3, 2024 Results on Nov 12, 2024 Nan Ya Plastics Corporation announced that they will report Q3, 2024 results on Nov 12, 2024 Reported Earnings • Aug 10
Second quarter 2024 earnings: Revenues exceed analyst expectations Second quarter 2024 results: Revenue: NT$66.4b (up 4.2% from 2Q 2023). Net income: NT$1.73b (up 84% from 2Q 2023). Profit margin: 2.6% (up from 1.5% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 15%. Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 4.9% growth forecast for the Chemicals industry in Taiwan. Duyuru • Aug 02
Nan Ya Plastics Corporation to Report Q2, 2024 Results on Aug 09, 2024 Nan Ya Plastics Corporation announced that they will report Q2, 2024 results on Aug 09, 2024 Major Estimate Revision • Aug 02
Consensus EPS estimates fall by 29% The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate fell from NT$1.89 to NT$1.34. Revenue forecast unchanged from NT$262.0b at last update. Net income forecast to grow 127% next year vs 32% growth forecast for Chemicals industry in Taiwan. Consensus price target of NT$54.51 unchanged from last update. Share price fell 2.5% to NT$48.45 over the past week. Upcoming Dividend • Jul 10
Upcoming dividend of NT$0.70 per share Eligible shareholders must have bought the stock before 17 July 2024. Payment date: 16 August 2024. Payout ratio is on the higher end at 83%, and the cash payout ratio is above 100%. Trailing yield: 1.5%. Lower than top quartile of Taiwanese dividend payers (4.2%). Lower than average of industry peers (2.2%). Duyuru • Jun 20
Nan Ya Plastics Corporation Approves Cash Dividend, Payable on August 16, 2024 Nan Ya Plastics Corporation approved a cash dividend of TWD 0.7 per share, at the board of directors or shareholders meeting held on June 19, 2024. Ex-rights (ex-dividend) trading date is July 17, 2024. Ex-rights (ex-dividend) record date is July 23, 2024. Payment date of cash dividend distribution is August 16, 2024. Major Estimate Revision • Jun 15
Consensus revenue estimates increase by 17% The consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from NT$223.6b to NT$260.8b. EPS estimate unchanged from NT$2.04 at last update. Chemicals industry in Taiwan expected to see average net income growth of 19% next year. Consensus price target broadly unchanged at NT$54.89. Share price was steady at NT$50.70 over the past week. Price Target Changed • Jun 08
Price target decreased by 8.7% to NT$55.39 Down from NT$60.64, the current price target is an average from 8 analysts. New target price is 9.0% above last closing price of NT$50.80. Stock is down 36% over the past year. The company is forecast to post earnings per share of NT$2.04 for next year compared to NT$0.80 last year. Reported Earnings • May 12
First quarter 2024 earnings: EPS and revenues miss analyst expectations First quarter 2024 results: EPS: NT$0.16 (up from NT$0.11 in 1Q 2023). Revenue: NT$58.6b (down 11% from 1Q 2023). Net income: NT$1.24b (up 43% from 1Q 2023). Profit margin: 2.1% (up from 1.3% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 13%. Earnings per share (EPS) also missed analyst estimates by 11%. Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has fallen by 62% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings. Duyuru • May 05
Nan Ya Plastics Corporation to Report Q1, 2024 Results on May 10, 2024 Nan Ya Plastics Corporation announced that they will report Q1, 2024 results on May 10, 2024 Major Estimate Revision • Apr 11
Consensus revenue estimates fall by 11% The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from NT$314.4b to NT$278.6b. EPS estimate fell from NT$2.50 to NT$2.14 per share. Net income forecast to grow 173% next year vs 21% growth forecast for Chemicals industry in Taiwan. Consensus price target of NT$64.49 unchanged from last update. Share price was steady at NT$57.20 over the past week. Duyuru • Mar 26
Nan Ya Plastics Corporation, Annual General Meeting, Jun 19, 2024 Nan Ya Plastics Corporation, Annual General Meeting, Jun 19, 2024. Reported Earnings • Mar 13
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: EPS: NT$0.80 (down from NT$4.05 in FY 2022). Revenue: NT$259.8b (down 27% from FY 2022). Net income: NT$6.31b (down 80% from FY 2022). Profit margin: 2.4% (down from 9.0% in FY 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 2.2%. Earnings per share (EPS) also missed analyst estimates by 32%. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 7.8% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings. Major Estimate Revision • Jan 16
Consensus EPS estimates fall by 15% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from NT$272.1b to NT$265.6b. EPS estimate also fell from NT$1.18 per share to NT$0.999 per share. Net income forecast to grow 271% next year vs 30% growth forecast for Chemicals industry in Taiwan. Consensus price target broadly unchanged at NT$67.43. Share price fell 4.8% to NT$62.00 over the past week. Major Estimate Revision • Jan 11
Consensus EPS estimates fall by 12%, revenue upgraded The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast increased from NT$295.8b to NT$302.3b. EPS estimate fell from NT$1.26 to NT$1.11 per share. Net income forecast to grow 222% next year vs 30% growth forecast for Chemicals industry in Taiwan. Consensus price target broadly unchanged at NT$68.05. Share price fell 2.6% to NT$63.90 over the past week. Major Estimate Revision • Dec 21
Consensus EPS estimates fall by 24% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from NT$312.1b to NT$295.8b. EPS estimate also fell from NT$1.65 per share to NT$1.26 per share. Net income forecast to grow 287% next year vs 33% growth forecast for Chemicals industry in Taiwan. Consensus price target broadly unchanged at NT$68.18. Share price fell 2.8% to NT$66.00 over the past week. Reported Earnings • Nov 15
Third quarter 2023 earnings: Revenues miss analyst expectations Third quarter 2023 results: Revenue: NT$67.3b (down 19% from 3Q 2022). Net income: NT$4.36b (up 29% from 3Q 2022). Profit margin: 6.5% (up from 4.1% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 9.1% p.a. on average during the next 3 years, compared to a 7.0% growth forecast for the Chemicals industry in Taiwan. Major Estimate Revision • Oct 12
Consensus EPS estimates increase by 11% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has improved. 2023 revenue forecast increased from NT$325.5b to NT$329.0b. EPS estimate increased from NT$2.27 to NT$2.53 per share. Net income forecast to grow 326% next year vs 2.9% growth forecast for Chemicals industry in Taiwan. Consensus price target broadly unchanged at NT$65.39. Share price rose 4.6% to NT$67.70 over the past week. Major Estimate Revision • Sep 20
Consensus revenue estimates fall by 14% The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from NT$380.8b to NT$328.4b. EPS estimate fell from NT$2.38 to NT$1.63 per share. Net income forecast to grow 254% next year vs 12% growth forecast for Chemicals industry in Taiwan. Consensus price target broadly unchanged at NT$66.39. Share price was steady at NT$68.40 over the past week. Reported Earnings • Aug 10
Second quarter 2023 earnings released: EPS: NT$0.12 (vs NT$1.81 in 2Q 2022) Second quarter 2023 results: EPS: NT$0.12 (down from NT$1.81 in 2Q 2022). Revenue: NT$63.7b (down 33% from 2Q 2022). Net income: NT$941.6m (down 93% from 2Q 2022). Profit margin: 1.5% (down from 15% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has remained flat whereas the company’s share price has increased by 3% per year. Major Estimate Revision • Jul 12
Consensus EPS estimates fall by 11% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from NT$327.5b to NT$317.1b. EPS estimate also fell from NT$2.10 per share to NT$1.87 per share. Net income forecast to shrink 6.9% next year vs 10% growth forecast for Chemicals industry in Taiwan . Consensus price target broadly unchanged at NT$67.35. Share price was steady at NT$69.40 over the past week. Major Estimate Revision • Jun 28
Consensus EPS estimates fall by 20% The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate fell from NT$3.97 to NT$3.17 per share. Revenue forecast steady at NT$345.0b. Net income forecast to grow 87% next year vs 39% growth forecast for Chemicals industry in Taiwan. Consensus price target broadly unchanged at NT$68.16. Share price fell 3.2% to NT$76.10 over the past week. Upcoming Dividend • Jun 22
Upcoming dividend of NT$3.00 per share at 3.8% yield Eligible shareholders must have bought the stock before 29 June 2023. Payment date: 28 July 2023. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 3.8%. Lower than top quartile of Taiwanese dividend payers (5.5%). In line with average of industry peers (3.5%). Duyuru • Jun 01
Nan Ya Plastics Corporation Approves Cash Dividend, Payable on July 28, 2023 Nan Ya Plastics Corporation approved a cash dividend of TWD 3 per share, at the AGM held on May 31, 2023. Ex-rights (ex-dividend) trading date is June 29, 2023. Ex-rights (ex-dividend) record date is July 5, 2023. Payment date of cash dividend distribution is July 28, 2023. Reported Earnings • May 12
First quarter 2023 earnings: Revenues and EPS in line with analyst expectations First quarter 2023 results: EPS: NT$0.11 (down from NT$1.90 in 1Q 2022). Revenue: NT$65.8b (down 36% from 1Q 2022). Net income: NT$866.3m (down 94% from 1Q 2022). Profit margin: 1.3% (down from 15% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 4.5% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Taiwan are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. Major Estimate Revision • Apr 12
Consensus EPS estimates increase by 35%, revenue downgraded The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from NT$369.8b to NT$339.4b. EPS estimate rose from NT$2.92 to NT$3.93. Net income forecast to grow 20% next year vs 0.1% growth forecast for Chemicals industry in Taiwan. Consensus price target up from NT$68.89 to NT$71.13. Share price was steady at NT$77.90 over the past week. Major Estimate Revision • Mar 31
Consensus EPS estimates fall by 37% The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate fell from NT$4.64 to NT$2.92 per share. Revenue forecast steady at NT$369.8b. Net income forecast to shrink 28% next year vs 2.1% growth forecast for Chemicals industry in Taiwan . Consensus price target broadly unchanged at NT$68.89. Share price was steady at NT$77.50 over the past week. Reported Earnings • Mar 11
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: EPS: NT$4.05 (down from NT$10.25 in FY 2021). Revenue: NT$355.2b (down 14% from FY 2021). Net income: NT$32.1b (down 61% from FY 2021). Profit margin: 9.0% (down from 20% in FY 2021). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 4.0%. Earnings per share (EPS) also missed analyst estimates by 20%. Revenue is forecast to grow 4.1% p.a. on average during the next 2 years, while revenues in the Chemicals industry in Taiwan are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Major Estimate Revision • Dec 21
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 EPS estimate fell from NT$5.47 to NT$4.81 per share. Revenue forecast steady at NT$370.0b. Net income forecast to shrink 22% next year vs 12% decline forecast for Chemicals industry in Taiwan. Consensus price target of NT$68.67 unchanged from last update. Share price fell 4.6% to NT$70.50 over the past week. Price Target Changed • Nov 16
Price target decreased to NT$68.67 Down from NT$78.25, the current price target is an average from 9 analysts. New target price is 5.2% below last closing price of NT$72.40. Stock is down 15% over the past year. The company is forecast to post earnings per share of NT$5.56 for next year compared to NT$10.25 last year. Reported Earnings • Nov 10
Third quarter 2022 earnings: EPS and revenues miss analyst expectations Third quarter 2022 results: EPS: NT$0.80 (down from NT$2.92 in 3Q 2021). Revenue: NT$82.6b (down 25% from 3Q 2021). Net income: NT$3.37b (down 85% from 3Q 2021). Profit margin: 4.1% (down from 21% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 13%. Earnings per share (EPS) also missed analyst estimates by 53%. Revenue is forecast to grow 1.3% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Taiwan are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Price Target Changed • Oct 12
Price target decreased to NT$72.75 Down from NT$79.63, the current price target is an average from 8 analysts. New target price is 12% above last closing price of NT$65.10. Stock is down 27% over the past year. The company is forecast to post earnings per share of NT$5.81 for next year compared to NT$10.25 last year. Major Estimate Revision • Oct 12
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast increased from NT$347.8b to NT$383.9b. EPS estimate fell from NT$6.36 to NT$5.81. Net income forecast to shrink 37% next year vs 21% decline forecast for Chemicals industry in Taiwan. Consensus price target down from NT$79.63 to NT$74.88. Share price fell 4.7% to NT$65.10 over the past week. Major Estimate Revision • Aug 26
Consensus EPS estimates fall by 17% The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from NT$405.3b to NT$401.2b. EPS estimate also fell from NT$7.53 per share to NT$6.24 per share. Net income forecast to shrink 15% next year vs 8.0% decline forecast for Chemicals industry in Taiwan. Consensus price target broadly unchanged at NT$83.13. Share price was steady at NT$70.20 over the past week. Reported Earnings • Aug 14
Second quarter 2022 earnings: EPS and revenues miss analyst expectations Second quarter 2022 results: EPS: NT$1.81 (down from NT$2.91 in 2Q 2021). Revenue: NT$94.7b (down 8.9% from 2Q 2021). Net income: NT$14.4b (down 38% from 2Q 2021). Profit margin: 15% (down from 22% in 2Q 2021). Revenue missed analyst estimates by 19%. Earnings per share (EPS) also missed analyst estimates by 11%. Over the next year, revenue is expected to shrink by 2.2% compared to a 2.5% decline forecast for the industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Duyuru • Jul 22
Nan Ya Plastics Corporation Appoints Chang-Te Chiu as Chief Information Security Officer, Effective August 1, 2022 Nan Ya Plastics Corporation announced appointment of Chang-Te Chiu, Acting Assistant Vice President of President Office, NPC, as Chief Information Security Officer, effective August 1, 2022. Price Target Changed • Jul 12
Price target decreased to NT$89.38 Down from NT$98.75, the current price target is an average from 9 analysts. New target price is 47% above last closing price of NT$60.60. Stock is down 30% over the past year. The company is forecast to post earnings per share of NT$7.61 for next year compared to NT$10.25 last year. Valuation Update With 7 Day Price Move • Jul 06
Investor sentiment deteriorated over the past week After last week's 21% share price decline to NT$67.00, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 11x in the Chemicals industry in Taiwan. Total returns to shareholders of 8.7% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at NT$37.78 per share. Upcoming Dividend • Jun 29
Upcoming dividend of NT$7.50 per share Eligible shareholders must have bought the stock before 06 July 2022. Payment date: 09 August 2022. Payout ratio is on the higher end at 76%, however this is supported by cash flows. Trailing yield: 8.9%. Within top quartile of Taiwanese dividend payers (6.3%). Higher than average of industry peers (6.9%). Major Estimate Revision • May 23
Consensus EPS estimates increase by 17% The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from NT$399.2b to NT$415.5b. EPS estimate increased from NT$7.86 to NT$9.21 per share. Net income forecast to shrink 12% next year vs 9.0% decline forecast for Chemicals industry in Taiwan. Consensus price target broadly unchanged at NT$98.88. Share price was steady at NT$82.20 over the past week. Reported Earnings • May 14
First quarter 2022 earnings: EPS and revenues miss analyst expectations First quarter 2022 results: EPS: NT$1.90 (down from NT$2.23 in 1Q 2021). Revenue: NT$102.1b (up 14% from 1Q 2021). Net income: NT$15.0b (down 15% from 1Q 2021). Profit margin: 15% (down from 20% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) also missed analyst estimates by 12%. Over the next year, revenue is expected to shrink by 6.0% compared to a 1.8% decline forecast for the industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth. Buying Opportunity • Apr 27
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 1.5%. The fair value is estimated to be NT$107, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.2% over the last 3 years. Earnings per share has grown by 28%. For the next 3 years, revenue is forecast to grow by 0.1% per annum. Earnings is forecast to decline by 8.7% per annum over the same time period. Reported Earnings • Mar 13
Full year 2021 earnings: Revenues exceed analyst expectations Full year 2021 results: Revenue: NT$411.7b (up 51% from FY 2020). Net income: NT$81.3b (up 216% from FY 2020). Profit margin: 20% (up from 9.4% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 3.0%. Over the next year, revenue is forecast to decline by -8.5% while the industry in Taiwan is not expected to grow. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Major Estimate Revision • Jan 06
Consensus EPS estimates increase by 12% The consensus outlook for earnings per share (EPS) in 2021 has improved. 2021 revenue forecast increased from NT$377.9b to NT$399.9b. EPS estimate increased from NT$8.98 to NT$10.09 per share. Net income forecast to shrink 11% next year vs 5.2% decline forecast for Chemicals industry in Taiwan. Consensus price target of NT$102 unchanged from last update. Share price was steady at NT$86.10 over the past week. Reported Earnings • Nov 10
Third quarter 2021 earnings released: EPS NT$3.23 (vs NT$1.31 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: NT$109.9b (up 62% from 3Q 2020). Net income: NT$23.1b (up 123% from 3Q 2020). Profit margin: 21% (up from 15% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 4% per year whereas the company’s share price has increased by 3% per year. Reported Earnings • Aug 11
Second quarter 2021 earnings released: EPS NT$2.91 (vs NT$0.27 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: NT$104.0b (up 72% from 2Q 2020). Net income: NT$23.0b (up NT$20.9b from 2Q 2020). Profit margin: 22% (up from 3.6% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Upcoming Dividend • Jul 21
Upcoming dividend of NT$2.40 per share Eligible shareholders must have bought the stock before 28 July 2021. Payment date: 25 August 2021. Trailing yield: 2.8%. Lower than top quartile of Taiwanese dividend payers (5.0%). In line with average of industry peers (2.9%). Major Estimate Revision • Jul 06
Consensus EPS estimates increase to NT$6.26 The consensus outlook for earnings per share (EPS) in 2021 has improved. 2021 revenue forecast increased from NT$307.9b to NT$334.1b. EPS estimate increased from NT$5.64 to NT$6.26 per share. Net income forecast to grow 18% next year vs 13% growth forecast for Chemicals industry in Taiwan. Consensus price target broadly unchanged at NT$94.22. Share price rose 3.1% to NT$85.90 over the past week. Reported Earnings • May 12
First quarter 2021 earnings released: EPS NT$2.23 (vs NT$0.13 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: NT$89.7b (up 37% from 1Q 2020). Net income: NT$17.7b (up NT$16.6b from 1Q 2020). Profit margin: 20% (up from 1.5% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.